EPISODE · Feb 5, 2026 · 9 MIN
Eli Lilly CFO Lucas Montarce Talks Weight Loss Pill, Business Outlook
from Bloomberg Talks · host Bloomberg
Eli Lilly Chief Financial Officer Lucas Montarce says their weight loss pill is on track to launch in the US in the second quarter, pending approval by the Food and Drug Administration. Montarce says they “feel good about the progress.” He speaks to Katie Greifeld.See omnystudio.com/listener for privacy information.
Embed this episode
NOW PLAYING
Eli Lilly CFO Lucas Montarce Talks Weight Loss Pill, Business Outlook
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.